Published 2 years ago • loading... • Updated 2 years agoShow Less IconStudy finds a treatment more effective than Ozempic for slimming down Summary by Australian Financial ReviewThe analysis found a rival drug made by Eli Lilly leads to faster and better weight loss, causing shares in to Wegovy maker Novo Nordisk’s to also drop.Share menu1 Articles1 ArticlesAllLeftCenterRight1Search IconSort IconAustralian Financial ReviewLean RightFactualityOwnershipStudy finds a treatment more effective than Ozempic for slimming downThe analysis found a rival drug made by Eli Lilly leads to faster and better weight loss, causing shares in to Wegovy maker Novo Nordisk’s to also drop.2 years ago·Sydney, AustraliaRead Full ArticleThink freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribeBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsCoverage DetailsTotal News Sources1Leaning Left0Leaning Right1Center0Last Updated2 years agoBias Distribution100% RightBias Distribution Too Big Arrow IconToo Big Arrow IconCaret Up Icon100% of the sources lean Right100% RightR 100%Factuality Info IconTo view factuality data please Upgrade to PremiumOwnership Info IconTo view ownership data please Upgrade to VantageAustralian Financial Review broke the news in Sydney, Australia 2 years ago on Wednesday, July 10, 2024.Too Big Arrow IconCaret Down IconSources are mostly out of (0)Similar News TopicsOzempic Plus IconEli Lilly Plus IconWegovy Plus IconShow AllBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsSimilar News TopicsOzempic Plus IconEli Lilly Plus IconWegovy Plus IconShow All